Breast Neoplasms Clinical Trials

960 clinical trials for Breast Neoplasms across international registries, including 119 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) — RECRUITING · PHASE3
• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) — RECRUITING · PHASE3
• A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) — RECRUITING · PHASE3
• Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer — RECRUITING · NA
• PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan — RECRUITING
• Slow Jogging for Breast Cancer Survivors — RECRUITING · NA
• A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) — RECRUITING · PHASE2
• A Study of LY4257496 in Participants With Cancer (OMNIRAY) — RECRUITING · PHASE1
• A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer — RECRUITING · PHASE2
• A Study of LY4337713 in Participants With FAP-Positive Solid Tumors — RECRUITING · PHASE1
• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — RECRUITING · PHASE3
• Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer — RECRUITING · PHASE1
• ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer — RECRUITING · PHASE3
• Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia — RECRUITING
• Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations — RECRUITING
• Breast Cancer, Reasoning, and Activity Intervention — RECRUITING · NA
• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence — RECRUITING
• Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer — RECRUITING
• Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score — RECRUITING · PHASE2
• J2J-MC-JZLL - preEMBER: A Phase 2, Open-label Study Evaluating Imlunestrant in Premenopausal Women with Estrogen Receptor-Positive, HER2-Negative Breast Cancer. — RECRUITING · PHASE2
• Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer — RECRUITING
• A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers — RECRUITING · PHASE1
• Fluorocholine PET/MR in Breast Cancer — RECRUITING
• Neoadjuvant Radiation in Locally Advanced Breast Cancer — RECRUITING · PHASE2
• A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study — RECRUITING · PHASE2
• Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer — RECRUITING · NA
• PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) — RECRUITING · PHASE2
• Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer — RECRUITING
• Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009) — RECRUITING · PHASE1
• Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) — RECRUITING · PHASE2
• AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases — RECRUITING
• Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study — RECRUITING · PHASE2
• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer — RECRUITING · PHASE2
• Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host — RECRUITING
• PREgnancy and FERtility Registry — RECRUITING
• A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer — RECRUITING · PHASE1
• Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery — RECRUITING · NA
• A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC) — RECRUITING
• DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes — RECRUITING
• Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea — RECRUITING
• ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) — RECRUITING
• Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models — RECRUITING
• ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies — RECRUITING
• Longitudinal Body Composition Assessment in Breast Cancer Patients — RECRUITING
• Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors — RECRUITING · NA
• Evaluation of Clinical Efficacy of Augmented Reality (AR)-Based Breast Cancer Medical Imaging Solution (SKIA-Breast) Localization Method in Breast Cancer Patients — RECRUITING · NA
• Tirzepatide Weight Loss for MRD+ Early Breast Cancer — RECRUITING · PHASE2
• A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer — RECRUITING · PHASE1
• Dissemination of BREASTChoice AIM1-B — RECRUITING · NA
• A Study of Breast Cancer Risk Factors and Outcomes of People in Florida — RECRUITING

Refine this search